# Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule

> **NCT01630668** · PHASE2 · COMPLETED · sponsor: **Micropharma Limited** · enrollment: 150 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** One-a-Day L. reuteri NCIMB 30242 supplement capsule
- **DIETARY_SUPPLEMENT:** One-a-Day placebo capsule

## Key facts

- **NCT ID:** NCT01630668
- **Lead sponsor:** Micropharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630668, "Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01630668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*